Barbara Hempstead, MD, PhD, Weill Cornell Medical College – “The Impact of Genomic Evolution on Clinical Challenges”
Speaker: Barbara Hempstead, MD, PhD, is the Senior Co-investigator and Center Co-Director, the O. Wayne Isom Professor of Medicine, and Co-Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medical College, New York. Dr. Hempstead is a practicing board-certified medical oncologist and hematologist and the principal investigator for numerous NIH research grants. Her research effort focuses on the study of growth factors, neurotrophins. She is evaluating the role of neurotrophins in regulating vessel growth, stabilization and regression, in models of vascular development and in tumors. Dr. Hempstead administratively oversees with Co-Division Chief, Dr. David Nanus, a faculty of 43 academic clinical researchers, translational scientists and basic scientists focused on cancer. These include clinical investigators with more than 100 ongoing clinical trials, most with translational components. She is a member of the Internal Advisory Board for the New York-Presbyterian-Weill Cornell Cancer Center, and has chaired international meetings in her area of research interest.
Location: Biodesign Auditorium
Web Cast: View Web Cast
Date & Time: April 5th, 2012 12:00 p.m.
Title: The Impact of Genomic Evolution on Clinical Challenges
Abstract: The major recent advances in genomic sequencing provide unparalleled opportunities to identify novel mechanisms that regulate susceptibility to human diseases, as well as disease pathogenesis and progression. However, the heterogeneity of human populations leads to complexity that complicates these analyses. Here, we will discuss clinical conundrums of human adaptation to extreme environments, and the impact of tumor heterogeneity on clinical prognoses, for which genetic profiling has uncovered unique and targetable pathways to improve patient outcomes.
Thank you and if you have questions please contact Amanda Wilber! And don’t forget, coffee will be served!
Amanda Wilber, Center for the Convergence of Physical Science and Cancer Biology
Arizona State University | P.O. Box 871504 | Tempe, AZ 85287
480.965.3860 | Fax: 480.965.6362